The adipocytokines such as IL-1β, leptin, and resistin released by the adipocytes control insulin sensitivity and inflammation, which also take part in the pathogenesis of NAFLD and its progression to NASH (Fjære et al. 2019; Silva et al. 2020). The gene discussed is IL1B; the disease is metabolic dysfunction-associated steatohepatitis.